Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
BMJ Mil Health ; 169(3): 236-242, 2023 Jun.
Article in English | MEDLINE | ID: mdl-34244378

ABSTRACT

INTRODUCTION: Military studies have investigated acute injuries associated with parachute jumps, but the literature does not address paratroopers' cumulative microtraumatic (CMT) injury risk, nor does it compare injury risks between paratroopers and the rest of the military population. This study determined whether US active duty Army paratroopers experienced greater injury risks than their non-paratrooper soldier counterparts and whether their injuries cost more to treat suggesting greater injury severity. METHODS: This retrospective study evaluated electronic medical records (2016-2018) for 31 621 paratroopers and a randomly selected comparison group of 170 715 non-paratrooper soldiers. Analyses included univariate and multivariate regression to quantify odds of injuries associated with risk variables and additional descriptive statistics. RESULTS: Paratroopers had a 57% increase in the odds of experiencing one or more injuries (OR=1.57, 95% CI: 1.52 to 1.62) after controlling for sex, race and age, with a greater proportion of acute injuries (OR=1.38, 95% CI: 1.34 to 1.42), relative to comparison group soldiers. Injury types proportionally higher among paratroopers included head trauma and shoulder injuries. Average injury cost among paratroopers was 13% lower than for non-paratroopers ($2470 vs $2830 per injury). Among both populations, acute injury costs were notably higher than for CMT injuries (paratroopers, $1710/$630; non-paratroopers, $1860/$880 per injury). CONCLUSIONS: Paratroopers were more likely to incur injury, especially an acute injury, than non-paratroopers. However, paratroopers' average injury costs were less. This may be due to higher return-to-duty motivations, fitness levels, and/or facility-specific cost of care. Future studies should investigate causes of injuries found to be proportionally higher among paratroopers.


Subject(s)
Aviation , Craniocerebral Trauma , Military Personnel , Humans , Electronic Health Records , Retrospective Studies
2.
BMJ Mil Health ; 168(4): 286-291, 2022 Aug.
Article in English | MEDLINE | ID: mdl-33547189

ABSTRACT

INTRODUCTION: Multiple studies report increasing cases of surgically treated pectoralis major (PM) muscle and tendon ruptures in military populations. Studies associate this with a growing popularity of weight-training and bench press exercises. Mild-to-moderate non-surgical PM traumas and overuse injuries have not been included in these studies despite evidence that these types of outpatient injuries account for the majority of the military's injury medical burden. METHODS: To assess rates of all PM injuries (ruptures, tears, strains, overuse), regardless of form of treatment, a PM injury surveillance definition was derived from International Classification of Disease (ICD) diagnostic codes used in routine US Army injury surveillance. A detailed clinical examination of 2016 Active Duty Army medical records was used to identify ICD codes commonly associated with PM injuries. Cost data were calculated and the definition applied to medical data from 2016 through 2018to assess trends. RESULTS: The estimated incidence of PM cases among soldiers was over 95% greater than if only considering severe surgical cases. Over 96% of army annual PM injury costs (direct medical and indirect from lost labour) were for outpatient services. PM injury incidence rates were not statistically different from 2016 to 2018. CONCLUSIONS: The PM injury surveillance definition provides a consistent means to monitor trends over time and evaluate the effectiveness of prevention efforts. PM injuries have a larger military impact than previously recognised and prioritised prevention strategies are needed to reduce them. Future interventions could focus on the bench press given its observed association with PM injuries.


Subject(s)
Military Personnel , Humans , Incidence , Pectoralis Muscles/injuries , Pectoralis Muscles/surgery , Rupture
3.
J Vet Cardiol ; 23: 129-141, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31174723

ABSTRACT

OBJECTIVES: The objective of this study was to report the signalment, presentation, clinical and imaging findings, interventions, and outcomes in a group of dogs with cor triatriatum dexter (CTD). ANIMALS: Seventeen client-owned dogs. METHODS: Medical records were reviewed retrospectively for signalment, history, physical examination findings, imaging and diagnostic findings, presence of concurrent congenital cardiac defects, description of interventional procedures, therapy information, and outcomes. RESULTS: Age at presentation ranged from two to 110 months, with 10 of 17 dogs (59%) aged <12 months. There was an equal distribution between the sexes. Peritoneal effusion was the most common presenting complaint, in 10 of 17 dogs (59%). The CTD was an isolated finding in 3 of 17 dogs (18%); the remaining 14 of 17 (82%) dogs had concurrent cardiac disease, with congenital anomalies present in 12 of 17 (70%). All except one of these 12 dogs had at least one additional condition affecting the right heart. Tricuspid valve dysplasia was the most common congenital comorbidity, present in 9 of 17 dogs (53%). Seven dogs (41%) underwent interventional treatment of their CTD. In 7 of 17 (41%) cases, the CTD was considered to be incidental and the dogs were asymptomatic; therefore, no interventions were performed. The remaining three cases were euthanized or lost to follow-up. CONCLUSIONS: Cor triatriatum dexter in dogs is commonly seen in association with other right-sided congenital cardiac anomalies and may be an incidental finding. Dogs with CTD obstructing right atrial inflow can have a good outcome after intervention. Dogs with no clinical signs associated with the CTD may remain asymptomatic into adulthood.


Subject(s)
Cor Triatriatum/veterinary , Dog Diseases/diagnosis , Dog Diseases/therapy , Animals , Ascitic Fluid , Cor Triatriatum/diagnosis , Cor Triatriatum/therapy , Dogs , Female , Heart Defects, Congenital/veterinary , Male , Retrospective Studies , Treatment Outcome , Tricuspid Valve/abnormalities
4.
Vet Comp Oncol ; 15(1): 105-117, 2017 Mar.
Article in English | MEDLINE | ID: mdl-25702795

ABSTRACT

Kinetic parameter variability may be sensitive to kinetic model choice, kinetic model implementation or patient-specific effects. The purpose of this study was to assess their impact on the variability of dynamic contrast-enhanced computed tomography (DCE-CT) kinetic parameters. A total of 11 canine patients with sinonasal tumours received high signal-to-noise ratio, test-double retest DCE-CT scans. The variability for three distributed parameter (DP)-based models was assessed by analysis of variance. Mixed-effects modelling evaluated patient-specific effects. Inter-model variability (CVinter ) was comparable to or lower than intra-model variability (CVintra ) for blood flow (CVinter :[4-28%], CVintra :[28-31%]), fractional vascular volume (CVinter :[3-17%], CVintra :[16-19%]) and permeability-surface area product (CVinter :[5-12%], CVintra :[14-15%]). The kinetic models were significantly (P<0.05) impacted by patient characteristics for patient size, area underneath the curve of the artery and of the tumour. In conclusion, DP-based models demonstrated good agreement with similar differences between models and scans. However, high variability in the kinetic parameters and their sensitivity to patient size may limit certain quantitative applications.


Subject(s)
Carcinoma/veterinary , Dog Diseases/diagnostic imaging , Dog Diseases/physiopathology , Paranasal Sinus Neoplasms/veterinary , Sarcoma/veterinary , Tomography, X-Ray Computed/veterinary , Analysis of Variance , Animals , Carcinoma/physiopathology , Contrast Media , Dogs , Kinetics , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/physiopathology , Sarcoma/physiopathology , Tomography, X-Ray Computed/methods
5.
J Small Anim Pract ; 52(6): 329-33, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21627662

ABSTRACT

An eight-year-old female spayed Airedale terrier with rapid recurrence of a nasal adenocarcinoma following image-guided intensity-modulated radiation therapy was treated with transnasal, image-guided cryotherapy. Ice ball size and location were monitored real-time with computed tomography-fluoroscopy to verify that the entire tumour was enveloped in ice. Serial computed tomography scans demonstrated reduction in and subsequent resolution of the primary tumour volume corresponding visually with the ice ball imaged during the ablation procedure. Re-imaging demonstrated focallysis of the cribriform plate following ablation that spontaneously resolved by 13 months. While mild chronic nasal discharge developed following cryoablation, no other clinical signs of local nasal neoplasia were present. Twenty-one months after nasal tumour cryoablation the dog was euthanased as a result of acute haemoabdomen. Image-guided cryotherapy may warrant further investigation for the management of focal residual or recurrent tumours in dogs, especially in regions where critical structures preclude surgical intervention.


Subject(s)
Adenocarcinoma/veterinary , Cryosurgery/veterinary , Dog Diseases/surgery , Nose Neoplasms/veterinary , Adenocarcinoma/surgery , Animals , Cryosurgery/methods , Dogs , Female , Neoplasm Recurrence, Local/surgery , Neoplasm Recurrence, Local/veterinary , Nose Neoplasms/surgery , Treatment Outcome
7.
J Small Anim Pract ; 50(7): 334-40, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19508490

ABSTRACT

OBJECTIVES: Canine intranasal neoplasia is commonly evaluated using computed tomography to indicate the diagnosis, to determine disease extent, to guide histological sampling location and to plan treatment. With the expanding use of magnetic resonance imaging in veterinary medicine, this modality has been recently applied for the same purpose. The aim of this study was to compare the features of canine intranasal neoplasia using computed tomography and magnetic resonance imaging. METHODS: Twenty-one dogs with confirmed intranasal neoplasia underwent both computed tomography and magnetic resonance imaging. The images were reviewed retrospectively for the bony and soft tissue features of intranasal neoplasia. RESULTS: Overall computed tomography and magnetic resonance imaging performed very similarly. However, lysis of bones bordering the nasal cavity and mucosal thickening was found on computed tomography images more often than on magnetic resonance images. Small amounts of fluid in the nasal cavity were more often seen on magnetic resonance images. However, fluid in the frontal sinuses was seen equally well with both modalities. CLINICAL SIGNIFICANCE: We conclude that computed tomography is satisfactory for evaluation of canine intranasal neoplasia, and no clinically relevant benefit is gained using magnetic resonance imaging for intranasal neoplasia without extent into the cranial cavity.


Subject(s)
Dog Diseases/pathology , Magnetic Resonance Imaging/veterinary , Nose Neoplasms/veterinary , Tomography, X-Ray Computed/veterinary , Animals , Bone Neoplasms/diagnosis , Bone Neoplasms/pathology , Bone Neoplasms/veterinary , Dog Diseases/diagnosis , Dogs , Nose Neoplasms/diagnosis , Nose Neoplasms/pathology , Retrospective Studies , Sensitivity and Specificity , Soft Tissue Neoplasms/diagnosis , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/veterinary
8.
J Vet Intern Med ; 18(2): 219-22, 2004.
Article in English | MEDLINE | ID: mdl-15058774

ABSTRACT

Paclitaxel (Taxol) was administered to 25 dogs with histologically confirmed malignant tumors at a dosage of 165 mg/m2 i.v. over 3-6 hours every 3 weeks. Dogs received premedication with antihistimines and corticosteroids to reduce hypersensitivity reactions. However, 64% of the dogs still experienced allergic reactions. Six dogs (24%) had grade 3 or 4 neutropenia, 6 dogs (24%) required hospitalization and 3 dogs (12%) died of sepsis. Five dogs (20%) had a partial response (osteosarcoma [2 dogs] mammary carcinoma [2 dogs] and malignant histiocytosis [1 dog]) for a median duration of 53 days. The overall toxicity was unacceptable at the 165 mg/m2 dose. Therefore, subsequent evaluations of paclitaxel in tumor-bearing dogs should a starting dose of 132 mg/m2 i.v. every 3 weeks.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Dog Diseases/drug therapy , Mammary Neoplasms, Animal/drug therapy , Osteosarcoma/veterinary , Paclitaxel/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/adverse effects , Diarrhea/veterinary , Dog Diseases/mortality , Dog Diseases/pathology , Dogs , Drug Administration Schedule , Female , Incidence , Infusions, Intravenous/veterinary , Male , Neutropenia/veterinary , Osteosarcoma/drug therapy , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Records/veterinary , Retrospective Studies , Survival Analysis , Thrombocytopenia/veterinary , Vomiting/veterinary , Wisconsin/epidemiology
9.
Vet Comp Oncol ; 1(2): 94-104, 2003 Jun.
Article in English | MEDLINE | ID: mdl-19379321

ABSTRACT

The medical records of 15 dogs with anal sac adenocarcinoma (ASAC) treated with concurrent curative-intent radiotherapy and mitoxantrone (MX) after surgical removal of the primary tumour were reviewed retrospectively. Radiation was prescribed at 15 daily fractions of 3.2 Gy for a total dose of 48 Gy. MX was given intravenously at a dosage of 5 mg m(-2) every 3 weeks for five treatment sessions. Twelve dogs received pelvic irradiation to include the regional lymph nodes (LNs) and three received radiation only to the perineum. At the time of diagnosis, four dogs were hypercalcaemic and seven dogs presented with regional LN metastasis. All the dogs with regional LN metastasis received pelvic irradiation, and in three cases, metastatic LNs were treated in the macroscopic disease setting. The median event-free survival was 287 days, and the median overall survival was 956 days. Acute and chronic radiation complications were common and non-life threatening, although chronic complications contributed to the decision to euthanize two dogs. The results observed in this retrospective analysis compare favourably with cases of ASAC in the literature related to treatment with surgery and/or chemotherapy.

10.
J Vet Intern Med ; 14(6): 578-82, 2000.
Article in English | MEDLINE | ID: mdl-11110377

ABSTRACT

Thirty-five dogs with 37 soft tissue sarcoma tumors that were incompletely excised and treated with radiotherapy in the postoperative, adjuvant setting were reviewed. Variables evaluated included age, sex, tumor site, tumor histology, total tumor radiation dose, radiotherapy field size. time to recurrence, and survival. The majority of tumors were fibrosarcomas and hemangiopericytomas, but small numbers of other tumor types were also represented. Total tumor radiation dose ranged from 42 to 57 Gy given in 3- to 4.2-Gy daily fractions on a Monday through Friday schedule. Overall median survival was 1,851 days. Median time to local recurrence was greater than 798 days. Soft-tissue sarcoma tumors at oral sites had a statistically significant lower median survival (540 days) as compared to other tumor sites (2,270 days). Radiotherapy may be a useful adjuvant therapy for incompletely excised soft-tissue sarcomas with a reasonable expectation for long-term patient survival.


Subject(s)
Dog Diseases/radiotherapy , Neoplasm Recurrence, Local/veterinary , Sarcoma/veterinary , Soft Tissue Neoplasms/veterinary , Age Factors , Animals , Dog Diseases/mortality , Dog Diseases/surgery , Dogs , Female , Histocytochemistry/veterinary , Lung Neoplasms/secondary , Lung Neoplasms/veterinary , Male , Radiotherapy, Adjuvant/veterinary , Retrospective Studies , Sarcoma/radiotherapy , Sarcoma/secondary , Sarcoma/surgery , Sex Factors , Soft Tissue Neoplasms/radiotherapy , Soft Tissue Neoplasms/surgery , Survival Analysis
11.
Vet Radiol Ultrasound ; 40(6): 606-10, 1999.
Article in English | MEDLINE | ID: mdl-10608687

ABSTRACT

Right lateral, left lateral and ventrodorsal radiographs were obtained in 20 normal ferrets (11 male). Three independent observers recorded measurements of the cardiac silhouette and results for each parameter were averaged. Long axis (length), short axis (width) and total of length plus width (L+W) were recorded in each view. Comparative measurements were calculated, including the ratio of L+W/length of thoracic vertebrae 5-8, and a modified vertebral heart score (VHS) method, measuring the heart in vertebral units. Measurements made in ventrodorsal views were usually larger than corresponding measurements in lateral views. Weight and most absolute measurements differed significantly between male and female ferret (P<0.05), but the differences in absolute measurements were not apparent when related to measures of body size (Ratio and modified VHS methods). Given the variability in body weight and size in ferrets, measurements of the cardiac silhouette normalized for body size may be more universally applicable than absolute measurements.


Subject(s)
Ferrets/anatomy & histology , Heart/diagnostic imaging , Age Factors , Animals , Body Constitution , Body Weight , Female , Heart/anatomy & histology , Male , Observer Variation , Radiography , Reference Values , Sex Factors , Thoracic Vertebrae/anatomy & histology , Thoracic Vertebrae/diagnostic imaging
12.
Clin Cancer Res ; 5(9): 2653-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10499645

ABSTRACT

This study represents part of an effort to determine the safety and efficacy of inhaled antineoplastic drugs, using pet dogs with spontaneously arising primary and metastatic lung cancers (including sarcoma, carcinoma, and malignant melanoma) as a model. Dogs received new formulations of either paclitaxel (PTX) or doxorubicin (DOX) by the inhalation route every 2 weeks using a specially designed aerosol device. Response was assessed radiographically using the indices of tumor nodule number and volume measurement of discrete pulmonary nodules. Dogs experiencing progressive disease after two consecutive treatments were crossed over to receive the alternate compound. In 24 dogs, 6 (25%) responses were noted including 5 partial responses (PR) and 1 complete response. These include 4 (22.2%) of 18 responses to DOX and 2 (13.3%) of 15 responses to PTX. Responses were noted with osteosarcoma (including three dogs with metastatic osteosarcoma that had failed prior systemic chemotherapy), liposarcoma, hemangiosarcoma, and undifferentiated sarcoma. One dog with mammary carcinoma experienced a 47% reduction in volume after PTX inhalation, just shy of PR criteria. One dog with liposarcoma is experiencing a long-term (>12 months) stabilization of disease on PTX. To date, no systemic toxicities have been observed with either PTX or DOX inhalations. Local (pulmonary) toxicity was not observed with PTX; however, changes consistent with pneumonitis/fibrosis were observed in some dogs receiving DOX. Only one of these dogs showed clinical signs, which were responsive to steroid and antitussive therapy. These data represent "proof of principle" for the avoidance of systemic toxicity while delivering efficacious local drug levels by the inhalation route.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents/administration & dosage , Dog Diseases/drug therapy , Lung Neoplasms/drug therapy , Lung Neoplasms/veterinary , Melanoma/drug therapy , Melanoma/veterinary , Sarcoma/drug therapy , Sarcoma/veterinary , Administration, Inhalation , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/blood , Antineoplastic Agents, Phytogenic/adverse effects , Antineoplastic Agents, Phytogenic/blood , Disease Models, Animal , Dog Diseases/blood , Dogs , Doxorubicin/administration & dosage , Doxorubicin/adverse effects , Doxorubicin/blood , Female , Lung Neoplasms/secondary , Male , Melanoma/secondary , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Paclitaxel/blood , Sarcoma/secondary
13.
Clin Tech Small Anim Pract ; 14(3): 170-6, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10457660

ABSTRACT

Applications for computed tomography (CT) and magnetic resonance imaging (MRI) scans of the head (excluding the brain and orbit) include the evaluation of neoplastic, inflammatory, and traumatic disorders of the skull (including the cranium, maxilla, mandible, and temporomandibular joints); of the nasal and oral cavities; of the nasopharynx and paranasal sinuses; and of the tympanic bullae. CT and MRI provide information not obtained with routine radiography and should be considered whenever advanced surgical or radiation therapy is anticipated. In this article, the role of CT and MRI in the diagnosis of head disorders will be reviewed and illustrated with case examples.


Subject(s)
Cat Diseases/diagnosis , Dog Diseases/diagnosis , Head/pathology , Animals , Cats , Dogs , Head/diagnostic imaging , Magnetic Resonance Imaging/veterinary , Tomography, X-Ray Computed/veterinary
15.
J Am Vet Med Assoc ; 215(11): 1644-9, 1620-1, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-14567428

ABSTRACT

Rickets was diagnosed in a 1-year-old cat with a history of weakness, osteopenia, and recurrent fractures. Processes causing rickets include vitamin D deficiency caused by inadequate, nutrition, lack of exposure to sunlight, defective metabolism of parent vitamin D to active metabolites, inherited vitamin D receptor defects, hypoparathyroidism, chronic renal failure, renal loss of phosphate, or malabsorptive states resulting from gastrointestinal or hepatic diseases. On the basis of analysis of serum 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D2 and D3 concentrations, serum biochemical analysis, and urinary fractional clearance of electrolytes, the causes of rickets in our cat, were most compatible with a combination of excessive loss of phosphorus via the kidneys and deficient or abnormal hepatic 25-hydroxylation of vitamin D. Calcifediol treatment and twice daily administration of phosphate salts resulted in clinical improvement and increases in mineralization of the skeleton, as evidenced on radiographic evaluation.


Subject(s)
Calcifediol/therapeutic use , Cat Diseases/metabolism , Phosphates/metabolism , Rickets/veterinary , Vitamin D/metabolism , Animals , Calcifediol/blood , Calcifediol/metabolism , Calcitriol/blood , Cat Diseases/drug therapy , Cats , Ergocalciferols/blood , Female , Kidney/metabolism , Phosphates/urine , Reference Values , Rickets/drug therapy , Rickets/metabolism , Vitamin D Deficiency/metabolism
16.
Vet Radiol Ultrasound ; 39(5): 475-81, 1998.
Article in English | MEDLINE | ID: mdl-9771602

ABSTRACT

Tumor and normal tissue response was assessed in 21 dogs with malignant nasal tumors given 42 Gy cobalt radiation in 9 or 10 fractions over 11 to 13 days. Local tumor/clinical relapse recurred in 68% of dogs, with a median relapse free interval (RFI) of 270 days. Median survival was 428 days. One year survival for all dogs was 60%. RFI and survival times are better than, or similar to, previous reports of dogs treated with radiotherapy only. Acute radiation effects were severe in one dog. Late effects were severe in six of 15 dogs (40%) with durable tumor control. Late effects included bilateral blindness (3), osteoradionecrosis (3), and seizures (1). These six dogs had a median survival of 705 days. Loss of vision occurred in at least one eye in nine dogs (47%). Tumor staging based on CT findings was predictive for survival duration. Tumor histology was not predictive of outcome. Labrador Retrievers were significantly over-represented. Despite comparable or improved tumor control and survival times provided by this accelerated protocol, relative to other radiotherapy reports, local failure remains the major cause of death, and late radiation effects can be severe in dogs with durable tumor control.


Subject(s)
Dog Diseases/radiotherapy , Nose Neoplasms/veterinary , Paranasal Sinus Neoplasms/veterinary , Radiation Injuries/veterinary , Animals , Cobalt Radioisotopes/adverse effects , Dogs , Dose-Response Relationship, Radiation , Female , Male , Neoplasm Staging/veterinary , Nose Neoplasms/pathology , Nose Neoplasms/radiotherapy , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/radiotherapy , Radiation Injuries/physiopathology , Radiotherapy/adverse effects , Radiotherapy/veterinary
17.
Vet Radiol Ultrasound ; 39(4): 337-40, 1998.
Article in English | MEDLINE | ID: mdl-9710138

ABSTRACT

Abdominal ultrasound examinations of 20 dogs with confirmed leptospirosis were reviewed retrospectively for renal abnormalities. Three dogs had a normal ultrasound examination. The remaining 17 dogs had sonographic abnormalities of the kidneys. These abnormalities, seen either alone or in combination, included renalmegaly (n=10), pyelectasia (n=9), increased cortical echogenicity (n=15), perinephric effusion (n=5), and a medullary band of increased echogenicity (n=6). At our institution, the medullary band of increased echogenicity has only been seen in dogs with leptospirosis and may therefore be a specific sonographic sign for this disease.


Subject(s)
Dog Diseases/diagnostic imaging , Kidney Diseases/veterinary , Leptospirosis/veterinary , Animals , Dilatation, Pathologic/diagnostic imaging , Dilatation, Pathologic/pathology , Dilatation, Pathologic/veterinary , Dog Diseases/pathology , Dogs , Exudates and Transudates , Female , Kidney/diagnostic imaging , Kidney/pathology , Kidney Cortex/diagnostic imaging , Kidney Cortex/pathology , Kidney Diseases/diagnostic imaging , Kidney Diseases/microbiology , Kidney Diseases/pathology , Kidney Medulla/diagnostic imaging , Kidney Medulla/pathology , Kidney Pelvis/diagnostic imaging , Kidney Pelvis/pathology , Leptospirosis/diagnostic imaging , Leptospirosis/pathology , Male , Retrospective Studies , Ultrasonography
18.
Radiat Oncol Investig ; 6(3): 128-34, 1998.
Article in English | MEDLINE | ID: mdl-9652911

ABSTRACT

The objective of this study was to document the utility of computed tomography (CT) and a three-dimensional (3-D) radiotherapy treatment planning system for assessing the development of acute radiation pneumonitis in a canine model. Fourteen dogs were randomly assigned to a nonirradiated control group or one of three radiation dose groups receiving a single fraction of either 12, 15, or 18 Gy delivered to two-thirds of the right hemithorax. CT and survey radiographs were performed in all dogs prior to and at defined intervals for up to 13 weeks following irradiation. All images were subjectively evaluated for development of radiation pneumonitis and CT images were quantitatively analyzed. Radiation pneumonitis was detected earlier with CT images than with radiographs. Quantitatively, functional lung volume and radiation pneumonitis lesion volume on CT images changed over time in all irradiated dogs. However, there was no statistically significant difference between the three radiation dose groups, but a marked difference between irradiated dogs and nonirradiated controls. These data suggest that CT is superior to survey radiography for the evaluation and quantification of acute radiation pneumonitis in this canine model. Quantification of acute radiation pneumonitis suggests future promise for evaluating the efficacy of modifiers to lessen the effects of irradiating normal lung tissue in this canine model.


Subject(s)
Radiation Pneumonitis/diagnostic imaging , Tomography, X-Ray Computed , Acute Disease , Animals , Disease Models, Animal , Dogs , Dose-Response Relationship, Radiation , Evaluation Studies as Topic , Follow-Up Studies , Radiation Pneumonitis/etiology , Radiotherapy Planning, Computer-Assisted , Random Allocation
19.
Vet Radiol Ultrasound ; 39(1): 4-8, 1998.
Article in English | MEDLINE | ID: mdl-9491510

ABSTRACT

Thoracic radiographs of 25 cats with pulmonary metastatic disease and confirmed primary tumors were reviewed retrospectively. Pulmonary patterns of metastasis were divided into three categories, described as well-defined interstitial nodules, ill-defined interstitial nodules or a diffuse pulmonary pattern. The latter consisted of an alveolar pattern with or without ill-defined pulmonary nodules and/or pleural effusion. More cats presented with pulmonary metastatic disease in the category of either ill-defined nodules (n = 10) or a diffuse pattern (n = 7). Within this group, the most commonly represented primary tumor was mammary gland adenocarcinoma.


Subject(s)
Cat Diseases/diagnostic imaging , Lung Neoplasms/veterinary , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/secondary , Adenocarcinoma/veterinary , Animals , Biopsy/veterinary , Carcinoma/diagnostic imaging , Carcinoma/secondary , Carcinoma/veterinary , Cats , Female , Lung/diagnostic imaging , Lung Diseases, Interstitial/diagnostic imaging , Lung Diseases, Interstitial/veterinary , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Male , Mammary Neoplasms, Animal/pathology , Pleural Effusion, Malignant/diagnostic imaging , Pleural Effusion, Malignant/veterinary , Pulmonary Alveoli/diagnostic imaging , Radiography , Retrospective Studies , Sarcoma/diagnostic imaging , Sarcoma/secondary , Sarcoma/veterinary
20.
Vet Radiol Ultrasound ; 38(6): 457-60, 1997.
Article in English | MEDLINE | ID: mdl-9402713

ABSTRACT

Primitive neuroectodermal tumors are composed of primitive neuroepithelial cells and include tumors of the central and peripheral nervous system. Neuroblastoma, medulloblastoma and retinoblastoma are examples of these rare malignant tumors that usually occur in young patients. This report describes a peripheral neuroblastoma in a 2 year old Boxer that presented with signs of renal disease and a palpable abdominal mass. The purpose of this paper is to describe the clinical presentation, imaging and immunohistological studies of this abdominal tumor in a young dog and to review the literature.


Subject(s)
Abdominal Neoplasms/veterinary , Dog Diseases/diagnosis , Neuroblastoma/veterinary , Abdominal Neoplasms/chemistry , Abdominal Neoplasms/diagnostic imaging , Abdominal Neoplasms/pathology , Animals , Biopsy , Chromogranin A , Chromogranins/analysis , Dog Diseases/diagnostic imaging , Dogs , Immunohistochemistry , Kidney/pathology , Male , Neuroblastoma/chemistry , Neuroblastoma/diagnostic imaging , Neuroblastoma/pathology , Synaptophysin/analysis , Ultrasonography , Vimentin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...